BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1876598)

  • 1. Pancreatic polypeptide and peptide YY inhibit the denervated canine pancreas.
    DeMar AR; Taylor IL; Fink AS
    Pancreas; 1991 Jul; 6(4):419-26. PubMed ID: 1876598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide YY inhibits pancreatic secretion via cholinergic pathways.
    Brodish RJ; Kuvshinoff BW; Fink AS; McFadden DW
    J Surg Res; 1993 Jul; 55(1):103-8. PubMed ID: 8105149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenergic pathways do not mediate peptide YY-induced inhibition of pancreatic exocrine secretion.
    Brodish RJ; Kuvshinoff BW; McFadden DW; Fink AS
    Pancreas; 1995 Mar; 10(2):187-93. PubMed ID: 7716143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pancreatic polypeptide and peptide YY on pancreatic blood flow and pancreatic exocrine secretion in the anesthetized dog.
    DeMar AR; Lake R; Fink AS
    Pancreas; 1991 Jan; 6(1):9-14. PubMed ID: 1994383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total denervation of the pancreas does not alter the pancreatic polypeptide-induced inhibition of pancreatic exocrine secretion in dogs.
    Köhler H; Nustede R; Barthel M; Müller C; Schafmayer A
    Res Exp Med (Berl); 1991; 191(5):359-69. PubMed ID: 1759047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide YY inhibits pancreatic secretion by inhibiting cholecystokinin release in the dog.
    Lluis F; Gomez G; Fujimura M; Greeley GH; Thompson JC
    Gastroenterology; 1988 Jan; 94(1):137-44. PubMed ID: 3335285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pancreatic denervation and atropine on the pancreatic response to secretin.
    Kuvshinoff BW; Demar AR; James L; McFadden DW; Fink AS
    Pancreas; 1993 Sep; 8(5):609-14. PubMed ID: 8302798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide YY: metabolism and effect on pancreatic secretion in dogs.
    Pappas TN; Debas HT; Taylor IL
    Gastroenterology; 1985 Dec; 89(6):1387-92. PubMed ID: 3840443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of natural peptide YY on blood flow and exocrine secretion of pancreas in dogs.
    Inoue K; Hosotani R; Tatemoto K; Yajima H; Tobe T
    Dig Dis Sci; 1988 Jul; 33(7):828-32. PubMed ID: 3378477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of natural peptide YY on pancreatic secretion and cholecystokinin release in conscious dogs.
    Hosotani R; Inoue K; Kogire M; Tatemoto K; Mutt V; Suzuki T; Rayford PL; Tobe T
    Dig Dis Sci; 1989 Mar; 34(3):468-73. PubMed ID: 2920652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory regulation of rat exocrine pancreas by peptide YY and pancreatic polypeptide.
    Putnam WS; Liddle RA; Williams JA
    Am J Physiol; 1989 Apr; 256(4 Pt 1):G698-703. PubMed ID: 2565088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin inhibits secretin-induced canine pancreatic response via a cholinergic mechanism.
    Kuvshinoff BW; Brodish RJ; James L; McFadden DW; Fink AS
    Gastroenterology; 1993 Aug; 105(2):539-47. PubMed ID: 8101500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin inhibits cholecystokinin-induced pancreatic protein secretion via cholinergic pathways.
    Brodish RJ; Kuvshinoff BW; McFadden DW; Fink AS
    Pancreas; 1995 May; 10(4):401-6. PubMed ID: 7792297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pancreatic denervation and atropine on the cholecystokinin-induced pancreatic exocrine response.
    Berry SM; Kuvshinoff BW; McFadden DW; Fink AS
    Pancreas; 1996 Jan; 12(1):84-91. PubMed ID: 8927624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide YY inhibits nutrient-, hormonal-, and vagally-stimulated pancreatic exocrine secretion.
    Lluis F; Gomez G; Fujimura M; Greeley GH; Thompson JC
    Pancreas; 1987; 2(4):454-62. PubMed ID: 3628240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of pancreatic exocrine secretion by galanin.
    Brodish RJ; Kuvshinoff BW; Fink AS; McFadden DW
    Pancreas; 1994 May; 9(3):297-303. PubMed ID: 7517543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intraluminal peptide YY on pancreatic function.
    Brodish RJ; Kuvshinoff BW; Fink AS; McFadden DW
    Int J Pancreatol; 1992 Oct; 12(2):153-60. PubMed ID: 1460330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide YY-induced inhibition of pancreatic exocrine secretion is not neurally mediated.
    DeMar AR; Meyer JH; Taylor IL; Fink AS
    Curr Surg; 1989; 46(1):10-3. PubMed ID: 2721231
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental studies on the interrelationship between organs mediated by peptide YY: effect on splanchnic circulation and exocrine pancreas in dogs.
    Sumi S; Inoue K; Tobe T
    Nihon Geka Hokan; 1990 May; 59(3):224-33. PubMed ID: 2130785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of peptide YY on cephalic, gastric, and intestinal phases of gastric acid secretion and on the release of gastrointestinal hormones.
    Guo YS; Singh P; Gomez G; Greeley GH; Thompson JC
    Gastroenterology; 1987 May; 92(5 Pt 1):1202-8. PubMed ID: 3557015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.